2012-09-17 06:01:17 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Markets Direct's, 'Aspergillosis - Pipeline Review, H2 2012', provides an overview of the Aspergillosis therapeutic pipeline. This report provides information on the therapeutic development for Aspergillosis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Aspergillosis. 'Aspergillosis - Pipeline Review, H2 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


Full Report Details at

- www.fastmr.com/prod/463723_aspergillosis_pipeline_review_h2_2012 ..


Scope

* A snapshot of the global therapeutic scenario for Aspergillosis.
* A review of the Aspergillosis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
* Coverage of products based on various stages of development ranging from discovery till registration stages.
* A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
* Coverage of the Aspergillosis pipeline on the basis of route of administration and molecule type.
* Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
* Key discontinued pipeline projects.
* Latest news and deals relating to the products.

Reasons to buy

* Identify and understand important and diverse types of therapeutics under development for Aspergillosis.
* Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
* Plan mergers and acquisitions effectively by identifying players with the most promising pipeline.
* Devise corrective measures for pipeline projects by understanding Aspergillosis pipeline depth and focus of Aspergillosis therapeutics.
* Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
* Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Keywords

Aspergillosis Therapeutic Products under Development, Key Players in Aspergillosis Therapeutics, Aspergillosis Pipeline Overview, Aspergillosis Pipeline, Aspergillosis Pipeline Assessment

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Aspergillosis Overview
Therapeutics Development
An Overview of Pipeline Products for Aspergillosis
Aspergillosis Therapeutics under Development by Companies
Aspergillosis Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Discovery and Pre-Clinical Stage Products
Comparative Analysis
Aspergillosis Therapeutics - Products under Development by Companies
Aspergillosis Therapeutics - Products under Investigation by Universities/Institutes
Companies Involved in Aspergillosis Therapeutics Development
Pfizer Inc.
Sigma-Tau S.p.A.
iCo Therapeutics Inc.
Basilea Pharmaceutica Ltd.
Novabiotics Ltd
Pacific Beach BioSciences, Inc
Aspergillosis - Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Drug Profiles
Isavuconazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PTX3 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Voriconazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Voriconazole + Micafungin - Drug Profile
Product Description
Mechanism of Action
R&D Progress
iCo-009 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
PB-200a - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Eraxis + Vfend - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Itraconazole - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SLP1002 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SLP0907 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
SLP0901 - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Aspergillosis Therapeutics - Drug Profile Updates
Aspergillosis Therapeutics - Dormant Products
Appendix
Methodology
Coverage
Secondary Research
Primary Research

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=463723&dt=t

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at www.fastmr.com/catalog/publishers.aspx?pubid=1033

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.